A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on …
Introduction This systematic review and meta‐analysis aims to investigate the mutual impact
of COVID‐19 and psoriasis to inform clinical practice and future research. Methods We …
of COVID‐19 and psoriasis to inform clinical practice and future research. Methods We …
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective
G Roccuzzo, E Gherardi, M Maio… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Immunomodulating therapies harness the power of the immune system to
combat disease. In advanced melanoma, immune checkpoint inhibitors have significantly …
combat disease. In advanced melanoma, immune checkpoint inhibitors have significantly …
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort …
YH Huang, SJ Hung, CN Lee, NL Wu, RC Hui… - American Journal of …, 2024 - Springer
Background For patients with psoriasis, discontinuation of biologics following remission has
become more common in daily practice. Objective We aimed to identify predictors and …
become more common in daily practice. Objective We aimed to identify predictors and …
Psoriasis and COVID-19 Infection Negatively Impact Each Other: an Analysis of 3581 Cases
X Wang, L Yuan, X Qiu, B Yang… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Objective To determine whether COVID-19 infection and psoriasis impact each other.
Methods WeChat app was used to carry out a questionnaire survey in individuals aged 18 …
Methods WeChat app was used to carry out a questionnaire survey in individuals aged 18 …
Development and external validation of a prediction model for the risk of relapse in psoriasis after discontinuation of biologics
S Huang, B Chen, Y Qi, X Duan, Y Bai - Frontiers in Medicine, 2024 - frontiersin.org
Background Some patients with psoriasis experience relapses shortly after discontinuation
of biologics. However, there is a lack of risk prediction tools to identify those at high risk of …
of biologics. However, there is a lack of risk prediction tools to identify those at high risk of …